Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 5Lung Neoplasms 5Brain Neoplasms 3Prostatic Neoplasms 2Esophageal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Thoracic Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Osteosarcoma 1Neuroblastoma 1Neoplasms by Site 1Mesothelioma, Malignant 1Melanoma 1Lymphoma 1Lung Diseases 1Gastric Adenocarcinoma 1Detection Rate of SLN ; Accuracy Rate of Lymph Node Metastasis 1Breast Neoplasms 1

Interventions

trifluridine tipiracil drug combination 1tipiracil 1andecaliximab 1Trifluridine 1S 1 (combination) 1Oxaliplatin 1Nivolumab 1Irinotecan 1Indocyanine Green 1Gastrectomy 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Gastric Adenocarcinoma × Indocyanine Green × Clear all
NCT05038098 2026-03-05

Magnetic Sentinel Lymph Node Mapping in Gastric Cancer

M.D. Anderson Cancer Center

Phase 1 Not yet recruiting
20 enrolled
Gastrointestinal

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡